deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00901615

Lenalidomide and R-CHOP in B-cell Lymphoma (R2CHOP-1)

A Phase IB Study of Escalating Doses of REVLIMID in Association With R-CHOP (R2-CHOP) in the Treatment of B-cell Lymphoma

Sponsor: Lymphoma Study Association

Conditions Follicular Lymphoma Lymphoma, Large B-Cell, Diffuse Mantle Cell Lymphoma Marginal Zone Lymphoma
Interventions Lenalidomide and R-CHOP
Updated 7 times since 2017 Last updated: Aug 21, 2018 Started: Jan 6, 2009 Primary completion: Nov 19, 2010 Completion: Nov 23, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Follicular Lymphoma and Lymphoma, Large B-Cell, Diffuse, this trial is completed. The trial is conducted by Lymphoma Study Association and has accumulated 7 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotUnknown Status~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Sep 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    Status: Unknown Status → Completed

▶ Show 2 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Unknown Status PHASE1_PHASE2

  2. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE1_PHASE2

    First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lymphoma Study Association
Data source: Lymphoma Study Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations